Vanguard Group
BDSX icon

Vanguard Group’s Biodesix BDSX Stock Holding History

Vanguard Group’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.31M Buy
192,138
+10,234
+6% +$75.4K ﹤0.01% 3703
2025
Q3 		$1.37M Sell
181,904
-7,764
-4% -$59.7K ﹤0.01% 3692
2025
Q2 		$1.07M Sell
189,668
-1,517
-0.8% -$12.2K ﹤0.01% 3725
2025
Q1 		$2.39M Hold
191,185
– – ﹤0.01% 3434
2024
Q4 		$5.85M Buy
191,185
+43,050
+29% +$1.27M ﹤0.01% 3210
2024
Q3 		$5.27M Buy
148,135
+2,810
+2% +$96.7K ﹤0.01% 3256
2024
Q2 		$4.45M Buy
145,325
+104,929
+260% +$3M ﹤0.01% 3305
2024
Q1 		$1.16M Sell
40,396
-192
-0.5% -$6.57K ﹤0.01% 3762
2023
Q4 		$1.49M Sell
40,588
-10,504
-21% -$330K ﹤0.01% 3702
2023
Q3 		$1.69M Sell
51,092
-13,530
-21% -$376K ﹤0.01% 3645
2023
Q2 		$1.59M Buy
64,622
+3,080
+5% +$92.3K ﹤0.01% 3737
2023
Q1 		$2.29M Buy
61,542
+6,222
+11% +$255K ﹤0.01% 3625
2022
Q4 		$2.54M Buy
55,320
+43,337
+362% +$1.18M ﹤0.01% 3577
2022
Q3 		$305K Buy
11,983
+2,983
+33% +$115K ﹤0.01% 4341
2022
Q2 		$295K Sell
9,000
-1,998
-18% -$65K ﹤0.01% 4410
2022
Q1 		$372K Sell
10,998
-7,807
-42% -$510K ﹤0.01% 4441
2021
Q4 		$1.99M Buy
18,805
+7
+0% +$914 ﹤0.01% 4040
2021
Q3 		$3.09M Buy
18,798
+591
+3% +$112K ﹤0.01% 3905
2021
Q2 		$4.81M Buy
18,207
+4,788
+36% +$1.51M ﹤0.01% 3631
2021
Q1 		$5.45M Buy
13,419
+1,930
+17% +$862K ﹤0.01% 3483
2020
Q4 		$4.63M Buy
+11,489
New +$3.58M ﹤0.01% 3395

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $17B AUM 39.66% 1-Year Est. Return

Vanguard Group's BDSX Position: Q4 2025 in Review

Vanguard Group increased its Biodesix (BDSX) stake by 5.6% in Q4 2025, buying an estimated $75.4K and bringing the position to 192,138 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #3703.

Vanguard Group first reported a position in BDSX in Q4 2020 and has held it in 21 quarters since. The position peaked at $5.85M in Q4 2024. 26 funds tracked by Wall St. Rank hold BDSX as of Q4 2025.

  • Vanguard Group held 192,138 shares of Biodesix worth $1.31M as of Q4 2025.
  • Vanguard Group bought 10,234 Biodesix shares in Q4 2025, an estimated $75.4K.
  • Biodesix made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3703 holding.
  • Vanguard Group first reported a position in Biodesix in Q4 2020 and has held it in 21 quarters since.
  • Vanguard Group's Biodesix position peaked at $5.85M in Q4 2024.
  • 26 funds tracked by Wall St. Rank held Biodesix as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.